(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Sana Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2027 to be $5,116,717,175, with the lowest SANA revenue forecast at $5,116,717,175, and the highest SANA revenue forecast at $5,116,717,175. On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $25,893,689,945, with the lowest SANA revenue forecast at $25,893,689,945, and the highest SANA revenue forecast at $25,893,689,945.
In 2029, SANA is forecast to generate $66,650,225,017 in revenue, with the lowest revenue forecast at $66,650,225,017 and the highest revenue forecast at $66,650,225,017.